Dissecting the restricted mean time in favor of treatment. | J Biopharm Stat;34(1): 111-126, 2024 Jan 02. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Dissecting the restricted mean time in favor of treatment.

Mao, Lu; Wang, Tuo.

Affiliation

Mao L; Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Wang T; Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

J Biopharm Stat ; 34(1): 111-126, 2024 Jan 02.

Article in En | MEDLINE | ID: mdl-37224223

Key words

Clinical trials; composite endpoints; estimands; recurrent events; restricted mean survival time

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Biopharm Stat Journal subject: FARMACOLOGIA Year: 2024 Type: Article Affiliation country: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Biopharm Stat Journal subject: FARMACOLOGIA Year: 2024 Type: Article Affiliation country: United States